IRF4 is involved in the pathological process of a variety of inflammatory diseases, including the promotion of interleukin(IL)-6 production in inflammatory bowel disease, which induces STAT3 expression in T lymphocytes to promote apoptosis followed by intestinal inflammation (Zhu et al. 2016). Here, IRF4 is linked to inflammatory bowel disease.